Current Illinois CancerCare Clinical Trals

2nd Line Metastatic, Stage 4 Patients with Progressive Disease


LungMAP

A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)


Search Again